Unison Medicines is delighted to announce an oversubscribed first close of $500k of financing from a syndicate of highly sophisticated biopharma angels. Unison will use the proceeds to conduct a series of animal studies of [...]
More news
We are happy to announce a new partnership with Granzer Regulatory Consulting & Services GmbH [...]
From bone flutes to synths, music has always been more than noise — it’s how [...]
The INCATE Selection Committee has chosen four new ventures for Stage I support. Meet the [...]
Did you know phages helped stop a cholera outbreak in Stalingrad during WWII? While antibiotics [...]
In 2025, it is possible — and increasingly common — to treat cancer but lose [...]
At INCATE, we are committed to providing support to early-stage innovators working on antimicrobial resistance [...]
On February 7, 2025, Swiss biopharmaceutical innovator BioVersys made its debut on the SIX Swiss [...]
On the evening of April 9, 2025, The Voltahalle in Basel was the stage of [...]
